Brainstem Tumor Model

Send This

Download

Comment

Favourite

more

Rating :

Rate It:

Embed :

Post a comment

Post Comment on Twitter Post Comment on SlideWorld

Comments:

Subscribe to follow-up comments

Notes

Hide Notes

Slide 1 :

Efficacy of Local Delivery 3-Bromopyruvate in the Treatment of Brainstem Tumors Cyrus Wong BS, Margaret Penno PhD, Andrey Volkov BA, Young Ko Phd, and George Jallo MD Johns Hopkins University, Baltimore Maryland

Slide 2 :

Epidemiology Brainstem location represents 8-15% of all brain tumors in the pediatric population 18-22% of all posterior fossa tumors 80% of all brainstem tumors are located in the pons Midbrain and medulla account for minority

Slide 3 :

Classification Systemfor Brainstem Tumors

Slide 4 :

Survival for Children with Diffuse Pontine Gliomas (CCG 9941) J Clin Oncol 20:3431-3437, 2002

Slide 5 :

Laboratory Methods: Rodent Tumor Model

Slide 6 :

Histological Analysis following Brainstem Tumor Cell Implantation

Slide 7 :

Radiographic Images

Slide 8 :

Kaplan – Meier Survival Curves

Slide 9 :

Choice of Chemotherapy Agents 3Br-PA used in hepatocellular tumors Intraarterial Intratumoral Tumor cells exhibit increased glycolysis Upregulate the glycolytic pathway for ATP Hypoxic environment of tumor cells Hexokinase catalyzes: glucose + ATP glucose-6-phosphate + ADP .

Slide 10 :

Results

Slide 11 :

3-Bromopyruvate 3-Bromopyruvate (3-BrPA) Potent inhibitor of hexokinase II Key enzyme if the first step for glycolysis Effective for the treatment of many cancer types Induces cell death by its ability to deplete cellular ATP

Slide 12 :

Experimental Design In vitro analysis of 3-bromopyruvate efficacy on F98 cells In vivo studies survival studies in the brainstem tumor model Toxicity study for 3-bromopyruvate

Slide 13 :

In vitro Study

Slide 14 :

Toxicity of 3-BrPA on Animal Weight

Slide 15 :

Animal Weight with Tumor Cells

Slide 16 :

Functional Rotorod Times

Slide 17 :

Overall Survival Overall survival delayed by several days as compared to controls No “cure” for these tumors

Slide 18 :

Conclusions The present study is to our knowledge the first to report on pre-clinical testing of a locally-delivered glycolysis inhibitor to a brainstem tumor. 3-BrPA constitutes a rational agent for brainstem tumor therapy.

Slide 19 :

Future Directions Tumor Cell Lines 9L Athymic rats Comparison of systemic versus local delivery Intra-arterial Intravenous Local Delivery Continuous infusion therapy Polymer delivery

Slide 20 :

Brain Tumor Neurolog...

Abrikossoff Tumor of...

Animal models of anx...

Towards a new model ...

A Rare Case and a Ra...

MRIBased Human Ventr...

Free Powerpoint Templates

	gjallo1@jhmi.edu 5 Years ago.



1622 Views, 0 favourite
PowerPoint Presentation on Brainstem Tumor Model or PowerPoint Presentation on Model of a brainste more PowerPoint Presentation on Brainstem Tumor Model or PowerPoint Presentation on Model of a brainstem tumors in a rat. less
More By User Flag as inappropriate Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details. Cancel